Literature DB >> 22645151

Porcine circovirus type 2 infection before and during an outbreak of postweaning multisystemic wasting syndrome on a pig farm in the UK.

B Wieland1, D Werling, A Nevel, A Rycroft, T G Demmers, C M Wathes, S Grierson, A J C Cook, S H Done, D Armstrong, C M Wathes.   

Abstract

The presence of porcine circovirus type 2 (PCV-2) and other pathogens before and during an outbreak of postweaning multisystemic wasting syndrome (PWMS) in pigs is evaluated in this study. At the time of the outbreak on a large commercial pig farm in the UK, serum samples and data were collected in two independent on-going research projects, one in weaned pigs and the other in sows. Serum samples of growing pigs and sows were PCV-2-antibody and PCR positive before and during the PMWS outbreak. Upon sequencing, PCV-2 isolates collected before the outbreak were identified as PCV-2a, and isolates collected during the outbreak were identified as PCV-2b, suggesting a shift of PCV-2 genotypes present on the farm. Pigs in the weaner study were from sows originating from different breeders and an association of sow origin and PCV-2 serostatus in offspring was found. Further, pigs had higher odds to be PCV-2 antigen positive if the sow was PCV-2 antibody positive around farrowing, the sow was of higher parity, and were less likely to test antigen positive if the sow was sourced from a particular breeder. The findings of this study highlight the potential role of the immune status of the sow on the occurrence of PMWS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22645151     DOI: 10.1136/vr.100276

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  7 in total

1.  A comparative efficacy test of 1 versus 2 doses of CIRCOQ PCV2 subunit vaccine against naturally occurring PCV2-type d in piglets with high maternally derived antibodies (MDAs) on a Vietnamese swine farm.

Authors:  Duy Tien Do; Khanh Doan Vinh Tran; Anh Tuyet Quach; David Lee; Frank Cj Chang; Carol Py Wu; Toan Nguyen Tat; Chanhee Chae
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

2.  Exposure to environmental stressors result in increased viral load and further reduction of production parameters in pigs experimentally infected with PCV2b.

Authors:  Robert Patterson; Amanda Nevel; Adriana V Diaz; Henny M Martineau; Theo Demmers; Christopher Browne; Bettina Mavrommatis; Dirk Werling
Journal:  Vet Microbiol       Date:  2015-03-20       Impact factor: 3.293

3.  Global gene expression profiling of myeloid immune cell subsets in response to in vitro challenge with porcine circovirus 2b.

Authors:  Bettina Mavrommatis; Victoria Offord; Robert Patterson; Mick Watson; Theo Kanellos; Falko Steinbach; Sylvia Grierson; Dirk Werling
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

4.  Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo.

Authors:  Robert Patterson; Thomas Eley; Christopher Browne; Henny M Martineau; Dirk Werling
Journal:  Vaccine       Date:  2015-10-21       Impact factor: 3.641

5.  Survey of porcine respiratory disease complex-associated pathogens among commercial pig farms in Korea via oral fluid method.

Authors:  Yeotaek Cheong; Changin Oh; Kunkyu Lee; Ki-Hyun Cho
Journal:  J Vet Sci       Date:  2017-09-30       Impact factor: 1.672

6.  Economic efficiency analysis of different strategies to control post-weaning multi-systemic wasting syndrome and porcine circovirus type 2 subclinical infection in 3-weekly batch system farms.

Authors:  Pablo Alarcon; Jonathan Rushton; Heiko Nathues; Barbara Wieland
Journal:  Prev Vet Med       Date:  2013-02-01       Impact factor: 2.670

7.  Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England - an economic disease model.

Authors:  Pablo Alarcon; Jonathan Rushton; Barbara Wieland
Journal:  Prev Vet Med       Date:  2013-03-13       Impact factor: 2.670

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.